IVI will complete the technology transfer by 2025 and the oral cholera vaccine will be manufactured by Biological E. Limited for India and international markets March 20, 2024. The International Vaccine Institute (IVI) is an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health. BE already has 9 vaccines with WHO PQ in its portfolio.